Asthma study probes deep lung inflammation
NCT ID NCT00203684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at inflammation in the small airways of the lungs in people with asthma. Researchers tested whether a steroid with small particles could reach these deep areas better than a steroid with large particles. 57 adults with mild to moderate asthma took part. The goal was to understand how different inhaled medications affect lung inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
57 people
The number who actually took part.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 18 to 50 years. Younger subjects are excluded due to greater concerns with respect to risks from radiation and bronchoscopy in children; older subjects due to greater risks of bronchoscopy. * Mild to moderate persistent asthma (forced expiratory volume in 1 second \[FEV1\] greater than or equal to 70% predicted {Hankinson, 1999 #266}; PC20 less than or equal to 8 mg/ml) and currently using only short acting inhaled beta agonists as needed for control of asthma symptoms. Exclusion Criteria: * The use of the following medications will exclude subjects from entering the study: * Oral or parenteral steroids within 6 months * Inhaled corticosteroids within 3 months * Antileukotrienes, b-adrenergic blocking agents, inhaled cromolyn sodium or nedocromil, macrolide antibiotics, or investigational drugs within 1 month * Drugs or exposures which, in the opinion of the investigators, could influence study results * Tobacco within 1 year or less than or equal to 5 pack years. * Pregnant women, lactating women, or women of childbearing age not willing to take precautions to avoid becoming pregnant during the study. * Subjects with upper respiratory infection or receiving an influenza vaccine within 6 weeks of the study. * Subjects with a history of allergy or adverse reaction to inhaled beta agonists or methacholine. * Subjects with clinically significant evidence of cardiovascular, central nervous system, endocrine, gastrointestinal, hematopoietic, hepatic, psychiatric, or respiratory (other than asthma) disease Eligibility will be determined by an investigator using the above inclusion/exclusion criteria. No subjects will be excluded based on race or gender. Subjects must be between 18 and 50 in order to avoid greater risks of bronchoscopy and, in those under 18, exposure to radiation. To avoid risks, women will not be enrolled if pregnant, lactating or of childbearing potential and unwilling to undertake appropriate precautions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Asthma and Cough Center
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test cut asthma Flare-Ups?
- Breathing tests face off: can extra lung measurements improve asthma diagnosis?
- The carbon label on your inhaler: can it sway a Doctor's choice?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a digital program help teens with chronic illnesses move to adult care?
- Why do some kids catch every cold? a 1,200-Child study hunts for immune clues